Adverse outcome (+) group (n = 31) | Adverse outcome (−) group (n = 103) | p value | |
---|---|---|---|
Age (year) | 62.42 ± 11.16 | 59.84 ± 13.36 | 0.330 |
Sex (male/female) | 14/17 | 47/56 | 0.963 |
RA volume (ml) | 58.72 ± 15.15 | 54.24 ± 12.96 | 0.143 |
LA volume (ml) | 43.18 ± 13.17 | 57.45 ± 17.65 | < 0.001 |
RV volume (ml) | 67.85 ± 22.16 | 52.67 ± 12.55 | < 0.001 |
LV volume (ml) | 50.80 ± 8.96 | 62.89 ± 9.72 | < 0.001 |
RA/LA volume ratio | 1.56 ± 0.82 | 1.01 ± 0.34 | < 0.001 |
RV/LV volume ratio | 1.39 ± 0.67 | 0.85 ± 0.25 | < 0.001 |
Obstruction area ratio | 0.38 ± 0.23 | 0.11 ± 12 | < 0.001 |
Clot aggressive volume ratio | 0.33 ± 0.25 | 0.16 ± 0.15 | 0.001 |
Clot lesion length (mm) | 41.09 ± 35.32 | 13.75 ± 22.45 | < 0.001 |
Clot maximal diameter (mm) | 35.24 ± 24.35 | 16.01 ± 15.37 | 0.036 |
Clot maximal area (mm2) | 374.36 ± 383.67 | 78.49 ± 139.83 | < 0.001 |